Telesis Bio Inc.
Telesis Bio Inc. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
May 28, 2021Telesis Bio Inc. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Sep 20, 2024Removed from listing - SEC Form 25 filed.
SourceTBIO stopped trading
Sep 20, 2024TBIO is linked to Telesis Bio Inc. and ended with final status "delisted".
Source
Entity Graph
Telesis Bio Inc.issuedTBIO
TBIOlisted onNASDAQ
TBIOresulted inunknown
Source-Backed Claims
- Telesis Bio Inc. entered into promissory notes with Novalis LifeSciences Investments II, L.P. and Northpond Ventures III, LP on November 4, 2024.8-K
- The aggregate principal amount borrowed under the promissory notes is $3.0 million.8-K
- The promissory notes will bear interest at the rate of 12.0% per annum.8-K
- The maturity date of the promissory notes is January 15, 2026.8-K
- The lenders hold more than 10% of Telesis Bio Inc.'s common stock.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.